Machine Learning Tool Predicts a Child’s Cisplatin-Induced Hearing Loss Risk
This tool allows doctors to tailor interventions like hearing monitoring or STS use based on each child's specific risk of cisplatin-induced hearing loss.
This tool allows doctors to tailor interventions like hearing monitoring or STS use based on each child's specific risk of cisplatin-induced hearing loss.
The newly released Counseling-Infused Audiologic Care offers a practical, person-centered guide to audiologic counseling rooted in evidence-based practice.
Knowing the auditory, vestibular, and cognitive issues associated with chronic illnesses can help hearing care professionals better treat patients with these conditions.
Investigational gene therapy DB-OTO showed promising improvements in hearing and speech development in children with otoferlin-related genetic hearing loss.
Researchers have identified and mapped diverse cell types in the cochlear nucleus, a critical part of the auditory system, advancing understanding of how our brains process sounds and paving the way for targeted treatments for auditory disorders.
Neuromod Devices Ltd. has secured €10 million in oversubscribed equity financing to expand the availability of its FDA-approved tinnitus treatment device, Lenire.
As a partner with the NBA and WNBA Minnesota basketball teams, Starkey will provide hearing protection for all home games.
A new study reveals that auditory stimuli significantly impact balance in individuals with vestibular hypofunction.
Henry Schein is donating essential healthcare products to be used for athlete health screenings at the 2025 Special Olympics World Winter Games in Turin, Italy.